| Company Name: |
TOSUN PHARM |
| Tel: |
020-66392521-118 18922260391 |
| Email: |
3004261881@qq.com |
|
| | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide Basic information |
| Product Name: | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide | | Synonyms: | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide;N-[2-(3,4-Diethoxyphenyl)ethyl]-3,4-diethoxybenzeneacetamide;Einecs 228-573-4;Benzeneacetamide, N-[2-(3,4-diethoxyphenyl)ethyl]-3,4-diethoxy-;2-(3,4-diethoxyphenyl)-N-[2-(3,4-diethoxyphenyl)ethyl]acetamide;N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide ISO 9001:2015 REACH;N-(3,4-Diethoxyphenethyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide;Drotaverine Amide impurity | | CAS: | 6298-46-0 | | MF: | C24H33NO5 | | MW: | 415.52 | | EINECS: | 228-573-4 | | Product Categories: | | | Mol File: | 6298-46-0.mol | ![N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide Structure](CAS/GIF/6298-46-0.gif) |
| | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide Chemical Properties |
| InChI | InChI=1S/C24H33NO5/c1-5-27-20-11-9-18(15-22(20)29-7-3)13-14-25-24(26)17-19-10-12-21(28-6-2)23(16-19)30-8-4/h9-12,15-16H,5-8,13-14,17H2,1-4H3,(H,25,26) | | InChIKey | WXWBNUBJVJKZAS-UHFFFAOYSA-N | | SMILES | C1(CC(NCCC2=CC=C(OCC)C(OCC)=C2)=O)=CC=C(OCC)C(OCC)=C1 |
| | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide Usage And Synthesis |
| Uses | N-[2-(3,4-Diethoxyphenyl)ethyl]-3,4-diethoxybenzeneacetamide is an impurity/degradation product of drotaverine(D689700); an antispasmodic. |
| | N-[2-(3,4-diethoxyphenyl)ethyl]-2-(3,4-diethoxyphenyl)acetamide Preparation Products And Raw materials |
|